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Heart E, Cline GW, Collis LP, Pongratz RL, Gray JP, Smith
PJS. Role for malic enzyme, pyruvate carboxylation, and mitochon-
drial malate import in glucose-stimulated insulin secretion. Am J
Physiol Endocrinol Metab 296: E1354–E1362, 2009. First published
March 17, 2009; doi:10.1152/ajpendo.90836.2008.—Pyruvate cy-
cling has been implicated in glucose-stimulated insulin secretion
(GSIS) from pancreatic -cells. The operation of some pyruvate
cycling pathways is proposed to necessitate malate export from the
mitochondria and NADP-dependent decarboxylation of malate to
pyruvate by cytosolic malic enzyme (ME1). Evidence in favor of and
against a role of ME1 in GSIS has been presented by others using
small interfering RNA-mediated suppression of ME1. ME1 was also
proposed to account for methyl succinate-stimulated insulin secretion
(MSSIS), which has been hypothesized to occur via succinate entry
into the mitochondria in exchange for malate and subsequent malate
conversion to pyruvate. In contrast to rat, mouse -cells lack ME1
activity, which was suggested to explain their lack of MSSIS. How-
ever, this hypothesis was not tested. In this report, we demonstrate that
although adenoviral-mediated overexpression of ME1 greatly aug-
ments GSIS in rat insulinoma INS-1 832/13 cells, it does not restore
MSSIS, nor does it significantly affect GSIS in mouse islets. The
increase in GSIS following ME1 overexpression in INS-1 832/13 cells
did not alter the ATP-to-ADP ratio but was accompanied by increases
in malate and citrate levels. Increased malate and citrate levels were
also observed after INS-1 832/13 cells were treated with the malate-
permeable analog dimethyl malate. These data suggest that although
ME1 overexpression augments anaplerosis and GSIS in INS-1 832/13
cells, it is not likely involved in MSSIS and GSIS in pancreatic islets.
dimethyl malate; pyrurate cycling; methyl succinate; anaplerosis
INSULIN SECRETION FROM PANCREATIC -cells is dependent on the
metabolism of secretory fuels. Apart from oxidative pathways
leading to the rise in the ATP-to-ADP ratio and resulting in the
ATP-dependent K (KATP) channel-dependent sequence of
events (18, 34), it has been proposed that efflux of tricarboxylic
acid (TCA) cycle intermediates out of the mitochondria (9, 26,
28) leads to the synthesis of other coupling factors, which
couple -cell metabolism with insulin secretion. Candidates
for these coupling factors include NADPH, short-chain acyl-
CoAs, glutamate, long-chain acyl-CoAs, and malonyl-CoA,
(20, 26, 31, 32, 40); however, evidence against malonyl-CoA
and glutamate has been presented (1, 29, 36).
The efflux of TCA cycle intermediates is contingent on the
anaplerotic influx of pyruvate into the TCA cycle. Conversion
of these TCA cycle intermediates back to pyruvate in the
cytosol occurs via pyruvate cycling pathways. Pyruvate cy-
cling has been implicated as an important component of glu-
cose-mediated insulin secretion. According to the proposed
model, pyruvate cycling can occur via the action of NADP-
dependent cytosolic malic enzyme (ME1), which enables the
pyruvate-malate (26) and pyruvate-citrate (9) pathways. It can
also take place via the action of cytosolic isocitrate dehydro-
genase (ICDc), which enables the pyruvate-isocitrate pathway
(41). In the malate-pyruvate pathway, malate is exported from
the mitochondria to the cytosol and converted directly to
pyruvate by ME1. In the pyruvate-citrate pathway, citrate is
exported from the mitochondria to the cytosol, where malate is
produced via aconitase, citrate lyase, and malate dehydroge-
nase reactions and then converted by ME1 to pyruvate. In the
pyruvate-isocitrate pathway, isocitrate is exported from the
mitochondria to the cytosol and can be oxidized by ICDc to
-ketoglutarate (-KG), which then can enter mitochondria
and be converted to malate via TCA cycle reactions.
A series of reports support the role of pyruvate cycling in
glucose-stimulated insulin secretion (GSIS) by demonstrating
that the level of GSIS correlates with an increase in pyruvate
cycling (24), whereas inhibition of the pyruvate-isocitrate shut-
tle, via inhibition of the ICDc or the citrate-isocitrate carrier,
impairs GSIS (21, 41). Inhibition of the pyruvate-malate and
pyruvate-citrate shuttles, via inhibition of ME1, also impairs
GSIS (13, 39), whereas potentiation of GSIS by the membrane-
permeable malate analog dimethyl malate (DMM) has been
proposed to take place via activation of pyruvate cycling (5).
However, the role of ME1 in GSIS has been disputed in a
recent report in which small interfering RNA-mediated inhibi-
tion of ME1 did not affect GSIS in rat islets (42).
Although all three pathways are operative in rat -cells, only
the isocitrate pathway operates in mouse -cells, likely be-
cause of the absence or relatively low level of NADP-
dependent malic enzyme activity (2, 17, 27). Absence of the
malate-pyruvate cycle in mouse islets was suggested to account
for their weak second phase of GSIS (39) and their inability to
secrete insulin in response to methyl succinate (MS), a mem-
brane-permeable succinate analog (27). It has been suggested
that MS-stimulated insulin secretion (MSSIS) is contingent on
the presence of ME1 activity (27), in such a way that succinate
import into the mitochondria is balanced by export of malate
and subsequent conversion of malate to pyruvate via ME1 in
the cytosol. However, this hypothesis has not been tested.
This study was undertaken to determine the mechanism by
which ME1 activity enhances insulin secretion and to test the
hypothesis that the response to MS is contingent on the
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presence of ME1 (27). Our data demonstrate that overexpres-
sion of ME1 potentiates GSIS in rat insulinoma INS-1 832/13
cells and that this effect is accompanied by an increase in
mitochondrial malate and citrate levels, whereas the ATP-to-
ADP ratio was not affected. However, introduction of ME1
activity into mouse pancreatic -cells did not significantly
augment GSIS, nor did it restore the secretory response to MS,
as previously hypothesized (27). These data suggest that al-
though ME1 regulates metabolism and GSIS in INS-1 832/13
cells, it is not directly involved in MSSIS or GSIS in islets.
MATERIALS AND METHODS
Cell preparation and culture. Clonal INS-1 832/13 cells and
MIN-6 cells were provided by Drs. Christopher Newgard (Duke
University) and Jun-ichi Miyazaki (Osaka University) and were main-
tained and cultured as described previously (19, 35). Male CD-1 mice
(Charles River) were euthanized by halothane. All procedures were
performed in accordance with the Institutional Guidelines for Animal
Care in compliance with US Public Health Service regulations and
were approved by the Institutional Animal Care and Use Committee
(IACUC no. 08-36) at the Marine Biological Laboratory. Pancreatic
islets were isolated by collagenase (Roche, Indianapolis, IN) digestion
(16). Islets were used immediately after isolation for viral transduction
or after an overnight culture in RPMI supplemented with 10% fetal
calf serum (Hyclone), penicillin-streptomycin, and 5 mM glucose and
were dispersed by incubation in Ca2/Mg2-free PBS, 3 mM EGTA,
and 0.002% trypsin, as described elsewhere (16). Islet cells were
plated on poly-D-lysine-coated coverslips (MatTek, Ashland, MA) in
35-mm petri dishes (for Ca2 studies and immunocytochemistry).
INS-1 832/13 cells (at 60–70% confluency), single mouse islet cells,
and whole mouse islets were transduced with Ad-ME1-GFP or Ad-
CV-GFP at 50 multiplicity of infection for 12 h; then viral medium
was replaced with appropriate growth medium. Insulin secretion and
Ca2 responses were determined 48 h after transduction. Transduc-
tion efficiency in single cells, determined from green fluorescent
protein (GFP) fluorescence, reached 90% under these conditions.
Islets and single cells were used 48 h after transduction. ME1
expression was monitored by GFP fluorescence and measurement of
ME1 mRNA and protein level, as well as ME1 enzymatic activity.
Purification of ME1. INS-1 832/13 cells, at 80% confluency, were
fractionated using a cytosol fractionation kit (Calbiochem) according
to the manufacturer’s protocol. Cytosolic fractions were further puri-
fied by NADPH affinity chromatography using the substrate activa-
tion method (47, 49). Briefly, 2,5-ADP-agarose was added (0.2 ml
volume of settled resin per volume of cytosol), and the suspension was
rocked for 1 h at 4°C and then centrifuged at 2,000 g for 5 min. The
supernatant was discarded, and the resin was washed five times with
PBS. For elution of ME1, the resin was washed with PBS containing
0.1% NP-40 and 5 mM NADPH (12). For removal of NADPH from
the eluate, the eluate was first concentrated using a centrifugal filter
(Amicon Ultra 50, Millipore, Billerica, MA). Retentate was reconsti-
tuted to the original volume with PBS, and this process was repeated
six times. Under these conditions, the concentration of NADPH in the
sample was 10 nM, as determined spectrophotometrically.
Malic enzyme activity. For determination of the rate of reductive
decarboxylation of malate, protein extracts (20 g) or NADPH
standard (1–100 nmol) was added to the reaction buffer [50 mM
HEPES (pH 7.4), 5 mM MnCl2, 50 M NADP, and 10 mM malate]
in a cuvette positioned inside a temperature-controlled chamber main-
tained at 37°C. The cuvette content was stirred to ensure proper
mixing. Fluorescence was measured at 340-nm excitation and 460-nm
emission on a fluorescence spectrophotometer (FluoroMax-3, Horiba
Jobin Yvon). A calibration curve was generated using known amounts
of NADPH (the product of malate reductive decarboxylation) in the
reaction buffer (17). For determination of the rate of NADPH oxida-
tion via oxidative carboxylation of pyruvate, protein extracts (20 g)
were added to the reaction buffer containing 50 mM HEPES (pH 7.4),
50 M NADPH, 10 mM pyruvate, 30 mM NaHCO3, and 5 mM
MnCl2. To correct for the chemical instability of NADPH, the rate of
enzymatic oxidation of NADPH was calculated as the difference
between the rates of total NADPH oxidation and nonenzymatic
NADPH oxidation, which were determined in the presence of enzyme
source and vehicle (PBS), respectively.
Construction of adenoviruses. Recombinant, replication-deficient type
5 adenoviruses expressing cytosolic firefly luciferase (Ad-CytoLuc) or
human ME1 from OriGene (Ad-ME1-GFP) were directly purchased
from (Ad-CytoLuc) or custom-constructed (Ad-ME1-GFP) by Vector
BioLabs (Philadelphia, PA). The expression of ME1 is under the
control of cytomegalovirus, which also directs the transcription of
GFP from an internal ribosome entry site. A control virus (Ad-CV-
GFP) was constructed in parallel. Viral titers were determined by the
plaque formation assay.
Immunocytochemistry. At 48 h after transduction, cells were
washed twice with PBS and fixed with 4% paraformaldehyde. Cells
were permeabilized in 0.1% Triton X-100 for 15 min and probed with
an mouse anti-human ME1 antibody (1:500 dilution; Abnova) and
rabbit anti-mouse insulin antibody (1:200 dilution; Immunostar) in
10% normal goat serum blocking solution for 1 h (Zymed Labs). A
negative control contained only blocking serum. The primary anti-
bodies were probed with Alexa Fluor 546 goat anti-mouse IgG and
Alexa Fluor 647 goat anti-rabbit IgG (1:1,000 dilution; Invitrogen) for
1 h. Cells were costained with the nuclear DNA marker 4,6-dia-
midino-2-phenylindole (DAPI, 300 nM; Invitrogen) before they were
imaged using a laser scanning confocal microscope (LSM 510 Meta,
Zeiss) with a 63 oil immersion objective (1.4 NA, 	0.7 m
z-resolution). Fluorescence images of x-y sections were recorded with
512 pixels per line. Raster point size was 60 nm, with an overall
lateral resolution of 0.2 m. GFP, Alexa Fluor 546, and Alexa Fluor
647 were excited at the 488-, 543-, and 633-nm laser lines, respec-
tively, with emission collected through a 488/543/633-nm dichroic
mirror. DAPI was imaged with two-photon excitation (Ultrafast Ti:
Sapphire, Coherent) tuned to 720 nm, and emission was collected
through a 700/488-nm dichroic mirror. Digital image overlay was
performed using Adobe Photoshop (version 6, Adobe Systems).
Ca2 measurement. Cells were loaded for 60 min with the Ca2
indicator Fura Red-AM (Molecular Probes, Eugene, OR) in the
presence of 0.2% Pluronic F127 in the growth medium. Cells were
washed in Krebs-Ringer bicarbonate [KRB; 5 mM glucose, 140 mM
NaCl, 30 mM HEPES, 4.6. mM KCl, 1 mM MgSO4, 0.15 mM
Na2HPO4, 0.4 mM KH2PO4, 5 mM NaHCO3, 2 mM CaCl2, and
0.05% BSA (pH 7.4)] and imaged on a laser scanning confocal
microscope (LSM 510 Meta) equipped with a heated stage. Fura Red
was excited using a 488-nm argon laser line, and emitted light was
collected with a 650-nm long-pass filter. At these settings, no con-
tamination from GFP was detected. Images were analyzed by the
LSM Image Browser software to derive Ca2 profiles. After the
experiment, confocal dishes were fixed with 4% paraformaldehyde,
and -cells were identified using rabbit anti-mouse insulin antibody
(1:200 dilution; Immunostar) probed with Alexa Fluor 647 goat
anti-rabbit IgG (1:1,000, Invitrogen). Only insulin-positive cells were
included in the analysis.
ATP levels. Changes in cytosolic ATP concentration were mea-
sured after cell infection with adenovirus carrying cytosolically tar-
geted luciferase (Ad-CytoLuc) using the luciferin-luciferase reaction
(33). Coverslips with cells, mounted inside a 35-mm dish (MatTek)
were placed directly onto the surface of the photocathode optical
window of a photomultiplier tube (model R464; Hamamatsu) housed
in a 37°C heated box. After application of 100 M luciferin, the signal
was allowed to reach a steady-state level, and changes in the concen-
tration of ATP in response to fuel addition were determined by
measurement of luminescence.
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O2 consumption. O2 consumption in single islets in response to fuel
additions was measured by the self-referencing method based on an
electrochemical O2 sensor moving between the “near” and “far”
position from the islet (48). The magnitude of the amperometric
current used for the reduction of O2 is proportional to the O2
concentration at that particular point.
Insulin secretion. Cells were preincubated for 2 h in the presence of
2 mM (INS-1 832/13 cells) or 4 mM (mouse islets) glucose in KRB
buffer. The amount of released insulin was determined after 30 min of
static incubation in the presence of secretory fuels using a radioim-
munoassay kit (Linco Research, St. Charles, MO) with rat insulin as
the standard. Data were normalized for protein content determined by
a micro-bicinchoninic acid protein assay kit (Pierce, Rockford, IL).
Tandem mass spectrometry analysis of metabolites. After 30 min of
incubation, cells were collected by centrifugation or subjected to rapid
fractionation to obtain mitochondria with use of a fractionation kit
(BioVision, Mountain View, CA). The pellets were suspended in 200
l of ice-cold acetonitrile-water (1:1) with 2 mM ammonium acetate
and 10 M [1,2-2H2]taurine (d4-taurine), disrupted by sonication, and
centrifuged. The supernatant was analyzed by tandem mass spectrom-
etry (LC-MS/MS). Metabolite levels were calculated from standard
curves, with d4-taurine as the internal standard, and normalized to
DNA concentration. LC-MS/MS analysis of metabolites was per-
formed on an Applied Biosystems API4000 QTrap interfaced to a
Shimadzu HPLC (LC-20AD, SIL-20AC, CTO-20A). Metabolites
were eluted from a 5-m, 120-A˚, 4.5  250 mm C16 column (Dionex
Aclaim Polar Advantage) at 40°C with acetonitrile-water buffered
with 2 mM ammonium acetate using a linear gradient from 5% to 95%
acetonitrile at a flow rate of 600 l/min. Metabolite concentrations
were determined by electrospray ionization monitoring of the posi-
tive-product ion transition pairs of ATP (506.0/158.9), ADP (426.0/
158.9), citrate (191.0/87.0), malate (133.0/71.0), and d4-taurine
(127.9/80.0).
Glucose oxidation. Groups of 30 islets or 2.5  105 INS-1 832/13
cells were incubated in a 0.6-ml Eppendorf tube without a cap in the
presence of 2 or 10 mM glucose and D-[U-14C]glucose (PerkinElmer;
250 mCi/mmol). The Eppendorf tube was placed upright in an airtight
sealed 20-ml scintillation vial, which contained an empty 1.5-ml
Eppendorf tube without a cap. After 90 min of incubation at 37°C with
agitation, the reaction was terminated by the injection of 10 M
rotenone, 10 M antimycin, and 1 mg KCN. The 1.5-ml tube was
emptied in the scintillation vial by injection of 500 l of 5% KOH.
After 60 min of incubation at room temperature, glucose oxidation
was determined by measurement of the KOH-trapped 14CO2.
Statistical analysis. Values are means 
 SE. Significance was
determined for multiple comparisons using one-way ANOVA; P 
0.05 was considered significant.
RESULTS
Kinetic characteristics of ME1. To obtain a large uniform
supply of highly concentrated enzyme needed for kinetic stud-
ies and to avoid possible contamination of the source with
other cytosolic enzymes, we purified ME1 from INS-1 832/13
cells. Enzyme activity following individual purification steps is
shown in Table 1. Purification resulted in an 	2,000-fold
increase in specific activity measured by oxidative carboxyla-
tion of pyruvate and reductive decarboxylation of malate. In
the final fraction, levels of oxidative carboxylation of pyruvate
reached 	85% of the reductive decarboxylation of malate. Km
values determined at pH 7.4 for malate and pyruvate were 240
M and 5.8 mM, respectively, in agreement with a previous
report on ME1 from liver and skeletal muscle (52).
Effect of ME1 overexpression on ME1 activity, GSIS, ATP-
to-ADP ratio, and malate and citrate levels. Adenoviral-me-
diated expression of ME1 cDNA in INS-1 832/13 cells resulted
in a significant increase in NADP-dependent malic enzyme
activity (from 8.1 
 2 to 115 
 22 mol NADPH mg cytosol
protein1 min1). Similar treatment of mouse islets led to the
introduction of protein-soluble NADP-dependent malic en-
zyme activity (from nondetectable levels to 123 
 23 mol
NADPH mg cytosol protein1 min1). Immunocytochemical
detection of transduced ME1 protein is shown in Fig. 1. In
INS-1 832/13 cells, ME1 overexpression significantly potenti-
ated glucose- and methyl pyruvate (MP)-stimulated, but not
MS-stimulated, secretion (Fig. 2A). KCl-induced secretion re-
mained unchanged, suggesting that a metabolic, rather than an
ionic, mechanism underlies the increase in secretion. The
fuel-dependent increase in intracellular ATP level was not
changed in ME1-overexpressing cells compared with controls,
as determined by measurements from the luciferin-luciferase
reaction in populations of INS-1 832/13 cells coexpressing
cytosolically targeted luciferase and ME1 or control (Fig. 2B).
Similarly, neither the ATP-to-ADP ratio nor the rate of glucose
oxidation (Table 2) was affected by ME1 overexpression. ME1
overexpression resulted in an increased glucose-dependent rise
in malate and citrate levels (Fig. 2, C and D) in INS-1 832/13
cells. Introduction of ME1 activity altered GSIS to a lesser
degree in mouse islets than in INS-1 832/13 cells (Fig. 3A).
As in INS-1 832/13 cells, ATP levels remained unaffected
(Fig. 3B).
Malate is a component of the malate-pyruvate pathway, and
its membrane-permeable analog DMM has been proposed to
counteract lipid-induced impairment of GSIS by enhancing
pyruvate cycling pathways in INS-1 832/13 cells (5). We have
confirmed that DMM nearly doubles GSIS in INS-1 832/13
cells (Fig. 2A), an effect that is accompanied by an increase in
malate and citrate levels (Fig. 2, C and D). However, we have
also demonstrated that DMM nearly doubles GSIS in isolated
mouse islets (Fig. 3A), where the malate-pyruvate shuttle is not
operative because of the absence of ME1. To clarify the mechanism
by which DMM potentiates GSIS, we tested the effect of DMM
on GSIS in the INS-1 832/13 cells and mouse islets overex-
pressing ME1. ME1 overexpression removed the potentiating
effect of DMM on glucose-mediated secretion in both cell
preparations, suggesting that activation of the malate-pyruvate
shuttle by malate does not directly underlie the mechanism of
DMM action (Figs. 2A and 3A). In accordance with these
findings, mitochondrial malate levels were increased in INS-1
832/13 cells following DMM treatment, and citrate levels were
increased as well. The DMM-dependent increase in malate and
citrate content was, however, removed after ME1 overexpres-
sion (Fig. 2, C and D).
Effect of ME1 on MSSIS and cytosolic Ca2. It has been
hypothesized (27) that, in contrast to rat islets, the lack of ME1
activity in mouse islets may explain the absence of MSSIS in
mouse islets. Contrary to this hypothesis, MSSIS was not
Table 1. Purification of ME1 from INS-1 832/13 cells
Step
Specific Activity,
mol NADPH  min1  mg protein1 Purification, fold change
Total homogenate 0.34
0.035 1
Cytosol 10
1.4 29.4
2,5-ADP-agarose 758
56 (687
34)* 2,229.4
Values are means 
 SE from 3–4 independent experiments. ME1, cytosolic
malic enzyme. *Oxidative carboxylation of pyruvate.
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restored in whole mouse islets after ME1 expression (Fig. 3A).
A group of islets infected with Ad-ME1-GFP is shown in Fig.
1B to demonstrate that infection with adenovirus was not
limited to the outer cell layer of islets. In a parallel experiment,
freshly isolated mouse islets were dispersed, yielding a popu-
lation of single islet cells. After overnight culture in poly-D-
lysine-coated culture vessels, single islet cells were infected
with Ad-ME1-GFP. Although this approach ensured that
95% of cells were infected, it did not change the outcome:
although 10 mM glucose stimulated secretion at 289 
 32% of
basal secretion, MS did not elicit secretion above the basal
level (98 
 16% of basal, where basal secretion was 18.4 

2.3 ng insulin mg protein1 h1).
A rise in cytosolic Ca2 accompanies insulin secretion and
has been shown to occur during MS stimulation in rat islet cells
(17). The inability of ME1-transduced mouse islet cells to
respond to MS was further defined by determination of the
Ca2 response in single mouse islet cells. Since GFP was
coexpressed in cells expressing ME1, the Ca2 indicator Fura
Fed (far red emission) was used to avoid cross-contamination
with the GFP signal (14). In contrast to other Ca2 indicators
such as fluo 4, the intensity of Fura Red decreases on binding
to Ca2 (15). Thus an increase in the Ca2 levels will be
paralleled by a decrease in the Fura Red signal. Of 120
(ME1-overexpressing) and 134 (control) single -cells, none
responded to MS, whereas 77% and 79% of cells, respectively,
Fig. 1. Cytosolic malic enzyme (ME1) expression in a single mouse -cell and
an intact islet. A: intracellular localization of human ME1 (hME1) protein was
determined using an anti-hME1 antibody and Alexa fluor 546. Insulin was
detected using anti-insulin antibody and Alexa fluor 647. Nuclei were detected
using 4,6-diamidino-2-phenylindole (DAPI). B: a group of mouse islets
infected with Ad-ME1-GFP. Strength of the green fluorescent protein (GFP)
signal (excitation at 488/550 nm) was used to determine infection efficiency.
Fig. 2. Effect of ME1 overexpression on insulin secretion, ATP, and metab-
olite levels in INS-1 832/13 cells. INS-1 832/13 cells were left untreated or
transduced with Ad-CV-GFP or Ad-ME1-GFP in the absence or presence of
Ad-CytoLuc at 50 multiplicity of infection. A: after 2 h of preincubation in the
presence of 2 mM glucose (G), insulin secretion in response to secretory fuels
at 10 mM or KCl was measured in static incubation over a 30-min period.
Basal secretion (B) at 2 mM glucose was 20.5 
 2.2, 23.2 
 3.1, and 22 
 2.7
ng insulin  mg protein1  h1 in untreated, Ad-CV-GFP-treated, and Ad-ME1-
GFP-treated cells, respectively. Nonstimulatory 2 mM glucose was present
during incubation with methyl pyruvate (MP), methyl succinate (MS), and
KCl; stimulatory 10 mM glucose was present during incubation with dimethyl
malate (DMM). Values are means 
 SE from 5 independent experiments.
B: ATP levels, measured in real time as relative light output, were determined
in a population of 	0.5  106 live cells using the luciferin-luciferase reaction
in response to 10 mM glucose and MP. Values are means 
 SE from 4
independent measurements. C and D: malate and citrate levels were deter-
mined in mitochondrial fractions using tandem mass spectrometry (LC-MS/
MS). *P  0.05 vs. Ad-CV-GFP.
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responded on subsequent stimulation with 10 mM glucose. (An
example of such a response is presented in Fig. 4, A and B,
respectively). These results suggest that there may be addi-
tional requirements for MSSIS besides ME1 activity or that
MSSIS is unrelated to the ME1 activity. This notion is further
supported by the fact that the mouse insulinoma cell line
(MIN-6) possesses cytosolic NADP-dependent malate dehy-
drogenase activity, as demonstrated by MacDonald (27) and
confirmed by us. However, these cells do not secrete insulin in
response to MS, whereas they exhibit robust secretion in
response to treatment with MP (Fig. 4C). To further assess the
effect of MS on mouse islet metabolism, O2 consumption was
measured in mouse islets exposed to MS. Although rat islets
demonstrated a sustained increase in O2 consumption after MS
application (Fig. 5B), mouse islets show only a transient
increase (Fig. 5A). The lack of sustained increase in O2
consumption in mouse islets was not changed by ME1 over-
expression (Fig. 5C).
DISCUSSION
Evidence for and against the role of ME1 in GSIS has been
previously reported (13, 39, 42). Mouse islets have been
Fig. 3. Effect of ME1 overexpression on insulin secretion and ATP levels in
mouse islets. Isolated mouse islets were left untreated or transduced with
Ad-CV-GFP or Ad-ME1-GFP in the absence (secretion, A) or presence (ATP
levels, B) of Ad-CytoLuc at 50 multiplicity of infection. A: after 2 h of
preincubation in the presence of 4 mM glucose, insulin secretion was measured
in response to secretory fuels at 10 mM or KCl in static incubation over a
30-min period. Basal secretion at 4 mM glucose was 3.2
 0.4, 3.7
 0.45, and
3.6 
 0.5 ng insulin  10 islets1  h1 in untreated, Ad-CV-GFP-treated, and
Ad-ME1-GFP-treated islets, respectively. Nonstimulatory 4 mM glucose was
present during incubation with MP, MS, and KCl. Stimulatory glucose (10
mM) was present during incubation with DMM. Values are means 
 SE from
3–4 independent experiments. B: ATP production, measured as relative light
output, was determined in a population of 	3.5  106 live islets cells
(obtained by dispersion of whole islets) using the luciferin-luciferase reaction
in response to stimulatory (10 mM) concentration of fuels. Values are means

SE from 3 independent experiments. *P  0.05 vs. Ad-CV-GFP.
Table 2. Effect of ME1 overexpression on ATP-to-ADP ratio
and glucose oxidation in INS-1 832/13 cells
Untreated Ad-CV-GFP Ad-Me1-GFP
ATP-to-ADP ratio
Basal 1.56
0.25 1.69
0.35 1.44
0.09
10 mM glucose 2.30
0.35 2.49
0.48 2.27
0.24
Glucose oxidation
Basal 4.2
0.52 3.9
0.42 4.0
0.49
10 mM glucose 5.8
0.74 5.6
0.76 5.8
0.68
Values are means 
 SE from 3 independent experiments. Glucose oxidation
is expressed as nmol  mg protein1  90 min1. GFP, green fluorescent protein.
Fig. 4. MS-mediated metabolic response is not contingent on ME1 activity.
A and B: a single mouse -cell Ca2 response in cells treated with Ad-ME1-
GFP and in control cells. Addition of secretory fuels at 10 mM is indicated by
arrows. Fura Red fluorescence is expressed as relative fluorescence units
(F1/F0, where F0 is mean baseline fluorescence). Note that Fura Red fluores-
cence intensity decreases upon Ca2 binding (15). C: MIN-6 cells do not
respond to MS, despite ME1 activity. After a 2-h preincubation in the presence
of 2 mM glucose, MIN-6 cells were exposed to secretory fuels at 10 mM.
Control cells were treated with 2 mM glucose (basal secretion). Insulin
secretion was measured in static incubation over a 30-min period. Basal
secretion was 56 
 5.5 insulin  mg protein1  h1. NADP-dependent malate
dehydrogenase activities were measured in the soluble protein fraction. Values
are means 
 SE from 4–5 independent experiments.
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reported to have no detectable ME1 activity (2, 17, 27);
however, this view has been recently challenged by reports
demonstrating the presence of Me1 mRNA (23) and enzymatic
activity in mouse islets, which was suggested to be signifi-
cantly correlated to the absence of DTT in the homogenization
buffer (51). We have tested this hypothesis by preparing mouse
islet extract with and without DTT. However, we did not detect
ME1 activity under either condition (data not shown). It is
possible that the strain of mouse we used (CD-1), in contrast to
the C57BL/6 mouse used by Xu et al. (51), is responsible for
these differences. Nevertheless, the level of ME1 activity has
been found to be significantly lower in mouse than in rat islets
(51), and ME1 activity was not measured in the earlier study
(23). In addition, a variety of regulatory events can mediate
translation of this enzyme (6). The consequential absence or
low level of malate-pyruvate and pyruvate-citrate cycling path-
ways was hypothesized to explain the lack of MSSIS in mouse
islets (27). If this hypothesis were correct, introduction of ME1
into mouse islets would enable operation of malate-pyruvate
and pyruvate-citrate pathways, restore the secretory response
of mouse islets to MS, and enhance GSIS. In addition, we
tested the effect of ME1 overexpression on the potentiating
effect of DMM on GSIS, proposed earlier to occur via activa-
tion of pyruvate cycling pathways (5).
ME1 overexpression increases GSIS and malate and citrate
levels in INS-1 832/13 cells. ME1 overexpression increased
GSIS in INS-1 832/13 cells and was paralleled by an increase
in mitochondrial malate and citrate levels. This suggests that
ME1 overexpression resulted in increased anaplerosis. An
increase in citrate synthesis will require an increase in malate,
but the mechanism by which malate is increased after ME1
overexpression is not clear. Pyruvate carboxylation to malate
in islets is typically thought to occur via the enzyme pyruvate
carboxylase (PC). It is possible that a side effect of ME1
overexpression is alteration of PC expression or activity, which
would result in increased malate formation from pyruvate.
However, ME1 is also capable of carboxylating pyruvate, as
has been demonstrated in liver, muscle, and brain tissue (8, 50,
52). Furthermore, we have demonstrated that ME1 purified
from the pancreatic cell line INS-1 832/13 is also capable of
mediating this reaction. Whether the reaction catalyzed by
ME1 will proceed toward malate formation (oxidative decar-
boxylation of pyruvate) or pyruvate formation (reductive car-
boxylation of malate) will be influenced by cytosolic levels and
subcompartmentalization of its reactants and products, malate
and pyruvate, as well as the NADPH-to-NADP ratio and the
concentration of CO2. Under increased cytosolic pyruvate levels
(e.g., glycolysis), we speculate that ME1 catalyzes the reaction
that proceeds toward malate, rather than toward pyruvate, result-
ing in the elevated levels of malate found in cells overexpress-
ing ME1. This would be further enhanced by the constitutively
high NADPH-to-NADP ratio (17) and the presence of CO2
(7). Cytosolic malate, a product of this reaction, can enter the
mitochondria and promote citrate synthesis and its export via
the tricarboxylate carrier. Although we have demonstrated that
ME1 overexpression increases malate levels, future studies are
required to unambiguously demonstrate whether PC, ME1, or
both are the principal mediators of enhanced malate and citrate
formation in cells overexpressing ME1.
It is not clear how much cytosolic pyruvate, derived from
glycolysis, can enter the mitochondria and how much can
undergo oxidative carboxylation to form malate via ME1. Our
view, however, is consistent with the notion that separate
pyruvate pools (mitochondrial and extramitochodrial) exist
within the -cell (24). Furthermore, studies suggest that, even
within the cytosol itself, a single metabolite can be distributed
within more than one pool (3, 4). In hepatocytes, data support-
ing the existence of at least two separate cytosolic pyruvate
pools, one associated with glycolysis and lactate (the glycolytic
pool) and another with mitochondrial pyruvate, have been presented
(38). A higher proportion of the glycolytic pyruvate pool avail-
able for carboxylation via ME1 in INS-1 832/13 cells than in
mouse islets could explain why ME1 overexpression increased
GSIS to a greater extent in INS-1 832/13 cells than in mouse
islets, and studies are underway to address this issue.
DMM potentiates GSIS by stimulating malate entry into the
mitochondria. The role of malate import into the mitochondria
was explored in studies with the membrane-permeable malate
analog DMM. If potentiation of GSIS by DMM requires
ME1-dependent malate-pyruvate cycling, then DMM would
not potentiate secretion in mouse islets, which lack ME1
Fig. 5. Differential effect of MS on O2 consumption in mouse and rat islets.
A: MS does not stimulate a sustained increase in O2 consumption in mouse
islets. B: MS elicits a sustained increase in O2 consumption in rat islets.
Addition of fuels (10 mM) is indicated by arrows. Each trace is representative
of 4–6 independent measurements. C: ME1 overexpression does not restore
MS-mediated O2 consumption in mouse islets. Values are means 
 SE from
3 independent experiments.
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enzymatic activity. Conversely, overexpression of ME1 would
enhance the potentiating effect of DMM on GSIS. However,
we observed that DMM potentiated GSIS in mouse islets to the
same extent as it did in INS-1 832/13 cells and that this effect
of DMM on GSIS was abolished by ME1 overexpression in
both preparations. Accordingly, DMM-dependent increases in
malate and citrate levels were abolished following ME1 over-
expression. In addition, the level of ME1 activity adjusted by
varying viral titer was inversely correlated to the DMM poten-
tiation of GSIS in mouse islets (data not shown). Thus malate
entry into the mitochondria seems to be an important step
during DMM-mediated potentiation of GSIS.
The potentiating effect of DMM on GSIS is likely a conse-
quence of maintaining a balance in charges and masses of
mitochondrial intermediates. In mitochondria, acetyl-CoA and
oxaloacetate (OAA), formed from decarboxylation and carbox-
ylation of pyruvate, respectively, condense to form citrate. It is
established that mitochondrial pyruvate carboxylation and de-
carboxylation occur in an 	4:6 ratio (22, 25). Thus malate,
entering the mitochondria from the cytosol, will replenish the
mitochondrial OAA pool and serve as a counterion to promote
citrate or isocitrate export on the tricarboxylate carrier via
electroneutral exchange of malate2 for tricarboxylate2 (37).
Thus the addition of DMM can promote all pyruvate cycling
pathways. Application of malate in the absence of glucose will
not lead to tricarboxylate export, since acetyl-CoA will be
depleted by condensation with OAA. Accordingly, application
of DMM in the absence of stimulatory levels of glucose does
not promote insulin secretion (data not shown).
When ME1 is overexpressed in INS-1 832/13 cells and
introduced into mouse islets, exogenously applied malate (as
DMM) will be converted to pyruvate, as the forward reaction
of ME1 will be favored by abundance of this substrate. This
will decrease the cytosolic malate pool available for entry to
the mitochondria. Interestingly, although malate has been
shown to accumulate inside the intact cells (46) and is trans-
ported out of isolated islet mitochondria (28), there is no report
demonstrating malate export out of the mitochondria of intact
cells under physiological levels of stimulatory glucose. How-
ever, citrate export out of the mitochondria in permeabilized
cells has been demonstrated (9). Cytosolic citrate can undergo
cleavage by citrate lyase to produce OAA and acetyl-CoA.
Although evidence has been presented against the involvement
of long-chain CoA (malonyl-CoA) (1, 36), short-chain acyl-
CoAs have been recently implicated in insulin secretion (30, 31).
The activity of isocitrate dehydrogenase has been reported to
be relatively high in mouse islets compared with rat and human
islets (26), perhaps to compensate for the lack of a shuttle
requiring ME1 activity. It is plausible that the transport of
malate, derived from DMM, to the mouse islet mitochondria is
balanced by export of isocitrate. Isocitrate can be converted to
-KG with generation of NADPH, and -KG enters the mito-
chondria.
MSSIS and malic enzyme. MSSIS was not restored after
introduction of ME1 in mouse islets, nor was MSSIS enhanced
in INS-1 832/13 cells after ME1 overexpression. The original
hypothesis linking MSSIS to the presence of ME1 activity (27)
is based on the observation that malate is the main metabolite
transported out of isolated mitochondria from rat and mouse
islets in response to pyruvate and succinate (28). In the cytosol
of rat -cells, malate would be converted to pyruvate by the
action of the cytosolic ME1 and pyruvate would reenter mito-
chondria (26), thus completing the cycle of the malate-pyru-
vate pathway. In the cytosol of mouse -cells, exported malate
would not be converted to pyruvate because of the absence or
a low level of ME1 activity. Differences between our results
and the above-described hypothesis (28) might be a result of
different types of preparations. Isolated mitochondria, in con-
trast to intact cells, cannot account for factors that are likely to
be important for transport, such as the metabolite concentration
gradient between mitochondrial and cytosolic compartments
(11, 45). It could be speculated, based on our results, that
malate export out of the mitochondria in response to MS does
not take place in intact -cells, and our data demonstrating the
Fig. 6. DMM enhances insulin secretion: role of malate
import into mitochondria. At initially high levels of cytosolic
pyruvate (glycolysis) and low levels of cytosolic malate, the
ME1-catalyzed reaction proceeds in the direction of malate
formation and cytosolic malate enters mitochondria, resulting
in increased output of citrate or isocitrate and enhanced
insulin secretion. However, when the level of cytosolic
malate becomes high (e.g., after DMM application), the
ME1-dependent reaction functions in reverse, favoring pyru-
vate formation (dotted line), resulting in decreased citrate/
isocitrate output and insulin secretion. Under the second
condition, increased ME1 activity (ME1 overexpression)
compared with cells with lower endogeneous (INS-1 832/13)
or low or absent (mouse islets) ME-1 activity facilitates
removal of cytosolic malate and removes DMM potentiation
of glucose-stimulated insulin secretion (GSIS) via decreased
citrate/isocitrate output. OAA, oxaloacetate; TCC, tricarboxylate
carrier; ICDc, cytosolic isocitrate dehydrogenase; -KG, -ke-
toglutarate; PC, pyruvate carboxylase; PDH, pyruvate dehydro-
genase; SCI, secretory coupling intermediates.
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lack of enhancement of MSSIS in INS-1 832/13 cells support
this notion. However, solely on the basis of the inability of
ME1 activity to restore MSSIS in the mouse -cells, the
possibility that malate is exported from the mitochondria in
exchange for succinate on the dicarboxylate carrier cannot be
completely ruled out (Fig. 6) (10). Differences in the activities
of mitochondrial metabolite carriers between mouse and rat
-cells might also be responsible for the failure of ME1 to
restore MSSIS in mouse. The absence or a low activity of the
specific dicarboxylate carrier can serve as an alternative expla-
nation for the failure of MS to trigger insulin secretion in
mouse islets as follows. Insufficient malate transport out of
mitochondria would halt succinate import and eventually cause
cessation of the insulin secretion response. Although MS is an
inefficient secretagogue in mouse islets, it does trigger a
transient increase in the ATP-to-ADP ratio (17) and O2 con-
sumption (Fig. 5) in these islets. In addition, MS fails to
stimulate insulin secretion in mouse insulinoma MIN-6 cells,
which possess high levels of ME1 activity (Fig. 4C). Although
the important role of mitochondrial carriers in GSIS has just
started to be recognized (21), there is still a lack of knowledge
about the relative importance of individual carriers for the
mechanism of action of a particular fuel secretagogue in the
-cell, and studies are underway to address these issues.
In summary, we have demonstrated that overexpression of
ME1 augments insulin secretion in INS-1 832/13 cells and that
the underlying mechanism likely involves increased citrate
synthesis, although the exact mechanism is not clear. The fact
that ME1 overexpression did not significantly affect GSIS in
isolated mouse islets is consistent with the recent report dem-
onstrating no effect of ME1 silencing on GSIS in primary rat
islets (42). We speculate that differences in size and compart-
mentalization of the metabolite pools within the cell (in this
case, the cytosolic pyruvate pool, which is available for car-
boxylation via the reverse reaction of ME1) between clonal
insulinoma cells and primary islets might underlie the failure of
ME1 expression to greatly enhance GSIS in mouse islets.
Transport of malate to the mitochondria likely promotes the
efflux of citrate or isocitrate and activation of the correspond-
ing cycling pathway, resulting in production of NADPH. Al-
though our view does not support the role of the pyruvate-
malate cycling pathway in GSIS and MSSIS, it is consistent
with key features demonstrated to play a role in insulin secre-
tion, including pyruvate carboxylation, tricarboxylate efflux,
and NADPH generation. Thus these data further the current
understanding of metabolic changes underlying insulin secre-
tion.
ACKNOWLEDGMENTS
We thank Prof. M. Meow for helpful comments and support in the
manuscript preparation.
J. P. Gray is a professor at the US Coast Guard Academy. The views here
are his own and not necessarily those of the Academy or other branches of the
US Government.
GRANTS
This work was supported by American Diabetes Association Grant 7-08-
JF-18 (E. Heart), Division of Research Resources Grant P41-RR-001395
(P. J. S. Smith), and National Institute of Diabetes and Digestive and Kidney
Diseases Grants DK-063984 (P. J. S. Smith) and DK-071071 (G. W. Cline).
REFERENCES
1. Antinozzi PA, Segall L, Prentki M, McGarry JD, Newgard CB.
Molecular or pharmacologic perturbation of the link between glucose and
lipid metabolism is without effect on glucose-stimulated insulin secretion.
A re-evaluation of the long-chain acyl-CoA hypothesis. J Biol Chem 273:
16146–16154, 1998.
2. Ashcroft SJ, Randle PJ. Enzymes of glucose metabolism in normal
mouse pancreatic islets. Biochem J 119: 5–15, 1970.
3. Berry MN. The function of energy-dependent redox reactions in cell
metabolism. FEBS Lett 117 Suppl: K106–K120, 1980.
4. Berry MN, Fanning DC, Grivell AR, Lewis SJ, Farrington CJ, Wal-
lace PG. Evidence for several separate functional pools of NAD(H) within
the cytoplasmic compartment of the hepatocyte. Biochem Soc Trans 8:
570, 1980.
5. Boucher A, Lu D, Burgess SC, Telemaque-Potts S, Jensen MV,
Mulder H, Wang MY, Unger RH, Sherry AD, Newgard CB. Biochem-
ical mechanism of lipid-induced impairment of glucose-stimulated insulin
secretion and reversal with a malate analogue. J Biol Chem 279: 27263–
27271, 2004.
6. Brown ML, Wise LS, Rubin CS. The molecular basis for a cytosolic
malic enzyme null mutation. Malic enzyme mRNA from MOD-1 null
mice contains an internal in-frame duplication that extends the coding
sequence by 522 nucleotides. J Biol Chem 263: 4494–4499, 1988.
7. Buanes T, Grotmol T, Landsverk T, Nafstad P, Raeder MG. Effects of
arterial pH and carbon dioxide on pancreatic exocrine H/HCO3 secretion
and secretin-dependent translocation of cytoplasmic vesicles in pancreatic
duct cells. Acta Physiol Scand 133: 1–9, 1988.
8. Bukato G, Kochan Z, Swierczynski J. Purification and properties of
cytosolic and mitochondrial malic enzyme isolated from human brain. Int
J Biochem Cell Biol 27: 47–54, 1995.
9. Farfari S, Schultz V, Corkey BE, Prentki M. Glucose-regulated anaple-
rosis and cataplerosis in pancreatic -cells. Possible implication of a
pyruvate/citrate shuttle in insulin secretion. Diabetes 49: 718–726, 2000.
10. Fiermonte G, Palmieri L, Dolce V, Lasorsa FM, Palmieri F, Runswick
MJ, Walker JE. The sequence, bacterial expression, and functional
reconstitution of the rat mitochondrial dicarboxylate transporter cloned via
distant homologs in yeast and Caenorhabditis elegans. J Biol Chem 273:
24754–24759, 1998.
11. Frezza C, Cipolat S, Scorrano L. Organelle isolation: functional mito-
chondria from mouse liver, muscle and cultured fibroblasts. Nat Protoc 2:
287–295, 2007.
12. Gray JP, Heck DE, Mishin V, Smith PJ, Hong JY, Thiruchelvam M,
Cory-Slechta DA, Laskin DL, Laskin JD. Paraquat increases cyanide-
insensitive respiration in murine lung epithelial cells by activating an
NAD(P)H:paraquat oxidoreductase: identification of the enzyme as thi-
oredoxin reductase. J Biol Chem 282: 7939–7949, 2007.
13. Guay C, Madiraju SR, Aumais A, Joly E, Prentki M. A role for
ATP-citrate lyase, malic enzyme, and pyruvate/citrate cycling in glucose-
induced insulin secretion. J Biol Chem 282: 35657–35665, 2007.
14. Hara M, Wang X, Kawamura T, Bindokas VP, Dizon RF, Alcoser SY,
Magnuson MA, Bell GI. Transgenic mice with green fluorescent protein-
labeled pancreatic -cells. Am J Physiol Endocrinol Metab 284: E177–
E183, 2003.
15. Haugland R. In: Handbook of Fluorescent Probes and Research Chem-
icals. Eugene, OR: Molecular Probes, 2002, sect. 20.4.
16. Heart E, Smith PJS. Rhythm of the -cell oscillator is not governed by
a single regulator: multiple systems contribute to oscillatory behavior.
Am J Physiol Endocrinol Metab 292: E1295–E1300, 2007.
17. Heart E, Yaney GC, Corkey RF, Schultz V, Luc E, Liu L, Deeney JT,
Shirihai O, Tornheim K, Smith PJS, Corkey BE. Ca2, NAD(P)H and
membrane potential changes in pancreatic beta-cells by methyl succinate:
comparison with glucose. Biochem J 403: 197–205, 2007.
18. Henquin J. Triggering and amplifying pathways of regulation of insulin
secretion by glucose. Diabetes 49: 1751–1760, 2000.
19. Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M,
Newgard CB. Isolation of INS-1-derived cell lines with robust ATP-
sensitive K channel-dependent and -independent glucose-stimulated in-
sulin secretion. Diabetes 49: 424–430, 2000.
20. Ivarsson R, Quintens R, Dejonghr S, Tsukamoto K, Veld P, Renstrom
E, Schuit FC. Redox control of exocytosis. Regulatory role of NADPH,
thioredoxin, and glutaredoxin. Diabetes 54: 2132–2142, 2005.
21. Joseph JW, Jensen MV, Ilkayeva O, Palmieri F, Alarcon C, Rhodes
CJ, Newgard CB. The mitochondrial citrate/isocitrate carrier plays a
E1361MITOCHONDRIAL MALATE IMPORT IN PANCREATIC -CELLS
AJP-Endocrinol Metab • VOL 296 • JUNE 2009 • www.ajpendo.org
regulatory role in glucose-stimulated insulin secretion. J Biol Chem 281:
35624–35632, 2006.
22. Khan A, Ling ZC, Landau BR. Quantifying the carboxylation of pyru-
vate in pancreatic islets. J Biol Chem 271: 2539–2542, 1996.
23. Li C, Nissim I, Chen P, Buettger C, Najafi H, Daikhin Y, Nissim I,
Collins HW, Yudkoff M, Stanley CA, Matschinsky FM. Elimination of
KATP channels in mouse islets results in elevated [U-13C]glucose metab-
olism, glutaminolysis, and pyruvate cycling but a decreased -aminobu-
tyric acid shunt. J Biol Chem 283: 17238–17249, 2008.
24. Lu D, Mulder H, Zhao P, Burgess SC, Jensen MV, Kamzolova S,
Newgard CB, Sherry AD. 13C NMR isotopomer analysis reveals a
connection between pyruvate cycling and glucose-stimulated insulin se-
cretion (GSIS). Proc Natl Acad Sci USA 99: 2708–2713, 2002.
25. MacDonald MJ. Glucose enters mitochondrial metabolism via both
carboxylation and decarboxylation of pyruvate in pancreatic islets. Me-
tabolism 42: 1229–1231, 1993.
26. MacDonald MJ. Feasibility of a mitochondrial pyruvate malate shuttle in
pancreatic islets. Further implication of cytosolic NADPH in insulin
secretion. J Biol Chem 270: 20051–20058, 1995.
27. MacDonald MJ. Differences between mouse and rat pancreatic islets:
succinate responsiveness, malic enzyme, and anaplerosis. Am J Physiol
Endocrinol Metab 283: E302–E310, 2002.
28. MacDonald MJ. Export of metabolites from pancreatic islet mitochondria
as a mean to study anaplerosis in insulin secretion. Metabolism 52:
993–998, 2003.
29. MacDonald MJ, Fahien LA. Glutamate is not a messenger in insulin
secretion. J Biol Chem 275: 34025–34027, 2000.
30. MacDonald MJ, Longacre MJ, Stoker SW, Brown LJ, Hasan NM,
Kendrick MA. Acetoacetate and -hydroxybutyrate in combination with
other metabolites release insulin from INS-1 cells and provide clues about
pathways in insulin secretion. Am J Physiol Cell Physiol 294: C442–C450,
2008.
31. MacDonald MJ, Smith AD 3rd, Hasan NM, Sabat G, Fahien LA.
Feasibility of pathways for transfer of acyl groups from mitochondria to
the cytosol to form short chain acyl-CoAs in the pancreatic beta cell. J Biol
Chem 282: 30596–30606, 2007.
32. Maechler P, Wollheim CB. Mitochondrial glutamate acts as a messenger
in glucose-induced insulin exocytosis. Nature 402: 685–689, 1999.
33. McElroy WD. The energy source for bioluminescence in an isolated
system. Proc Natl Acad Sci USA 33: 342–345, 1947.
34. Misler S, Barnett G, Gilis KD, Pressel DM. Electrophysiology of
stimulus-secretion coupling in human -cells. Diabetes 41: 1221–1228,
1992.
35. Miyazaki J, Araki K, Yamato E, Ikegami H, Asano T, Shibasaki Y,
Oka Y, Yamamura K. Establishment of a pancreatic beta cell line that
retains glucose-inducible insulin secretion: special reference to expression
of glucose transporter isoforms. Endocrinology 127: 126–132, 1990.
36. Mulder H, Lu D, Finley J, An J, Cohen J, Antinozzi PA, McGarry JD,
Newgard CB. Overexpression of a modified human malonyl-CoA decar-
boxylase blocks the glucose-induced increase in malonyl-CoA level but
has no impact on insulin secretion in INS-1-derived (832/13) beta-cells.
J Biol Chem 276: 6479–6484, 2001.
37. Palmieri F. The mitochondrial transporter family (SLC25): physiological
and pathological implications. Pflu¨gers Arch 447: 689–709, 2004.
38. Peuhkurinen KJ, Hiltunen JK, Hassinen IE. Metabolic compartmenta-
tion of pyruvate in the isolated perfused rat heart. Biochem J 210:
193–198, 1983.
39. Pongratz RL, Kibbey RG, Shulman GI, Cline GW. Cytosolic and
mitochondrial malic enzyme isoforms differentially control insulin secre-
tion. J Biol Chem 282: 200–207, 2007.
40. Prentki M, Vischer S, Glennon MC, Regazzi R, Deeney JT, Corkey
BE. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling
factors in nutrient-induced insulin secretion. J Biol Chem 267: 5802–5810,
1992.
41. Ronnebaum SM, Ilkayeva O, Burgess SC, Joseph JW, Lu D, Stevens
RD, Becker TC, Sherry AD, Newgard CB, Jensen MV. A pyruvate
cycling pathway involving cytosolic NADP-dependent isocitrate dehydro-
genase regulates glucose-stimulated insulin secretion. J Biol Chem 281:
30593–30602, 2006.
42. Ronnebaum SM, Jensen MV, Hohmeier HE, Burgess SC, Zhou YP,
Qian S, Macneil D, Howard A, Thornberry N, Ilkayeva O, Lu D,
Sherry AD, Newgard CB. Silencing of cytosolic or mitochondrial iso-
forms of malic enzyme has no effect on glucose-stimulated insulin
secretion from rodent islets. J Biol Chem 283: 28909–28917, 2008.
45. Salnikov V, Lukyanenko YO, Frederick CA, Lederer WJ, Luky-
anenko V. Probing the outer mitochondrial membrane in cardiac mito-
chondria with nanoparticles. Biophys J 92: 1058–1071, 2007.
46. Schuit F, De VA, Farfari S, Moens K, Pipeleers D, Brun T, Prentki M.
Metabolic fate of glucose in purified islet cells. Glucose-regulated anaple-
rosis in beta cells. J Biol Chem 272: 18572–18579, 1997.
47. Skorkowski EF, Storey KB. Affinity chromatography on 2,5-ADP-
Sepharose 4B for purification of malic enzyme from crustacean muscle.
J Chromatogr 389: 427–432, 1987.
48. Smith PJS, Sanger RH, Messerli MA. Electrochemical methods for
neuroscience. In: Principles, Development and Applications of Self-Ref-
erencing Electrochemical Microelectrodes to the Determination of Fluxes
at Cell Membranes. Boca Raton, FL: CRC, 2007, p. 373–405.
49. Swierczynski J. Purification and some properties of extramitochondrial
malic enzyme from rat skeletal muscle. Biochim Biophys Acta 616: 10–21,
1980.
50. Swierczynski J, Aleksandrowicz Z, Zelewski L. Carboxylation of pyru-
vate via extramitochondrial malic enzyme in rat skeletal muscle. Acta
Biochim Pol 33: 47–54, 1986.
51. Xu J, Han J, Long YS, Lock J, Weir GC, Epstein PN, Liu YQ. Malic
enzyme is present in mouse islets and modulates insulin secretion. Dia-
betologia 51: 2281–2289, 2008.
52. Zelewski M, Swierczynski J. Malic enzyme in human liver. Intracellular
distribution, purification and properties of cytosolic isozyme. Eur J Bio-
chem 201: 339–345, 1991.
E1362 MITOCHONDRIAL MALATE IMPORT IN PANCREATIC -CELLS
AJP-Endocrinol Metab • VOL 296 • JUNE 2009 • www.ajpendo.org
